Development of Candidemia on Caspofungin Therapy: a Case Report

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Jorge Mora-Duarte, Robert F. Betts, Coleman Rotstein et al. · New England Journal of Medicine · 2002 · 1.4K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Thomas J. Walsh, Hedy Teppler, Gerald R. Donowitz et al. · New England Journal of Medicine · 2004 · 921 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Antifungal Susceptibility of<i>Candida</i>Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins

Duncan M. Kuhn, Tracy P. George, J. Chandra et al. · Antimicrobial Agents and Chemotherapy · 2002 · 758 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

J. Maertens, Issam Raad, G. Petrikkos et al. · Clinical Infectious Diseases · 2004 · 662 citations · Full text

Medicine, Microbiology, Pharmacology +17

International Surveillance of Bloodstream Infections Due to <i>Candida</i> Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program

Michael A. Pfaller, Daniel J. Diekema, Ronald N. Jones et al. · Journal of Clinical Microbiology · 2001 · 523 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15